Halozyme Therapeutics (HALO) Enterprise Value Growth (1y) (2011 - 2026)
Halozyme Therapeutics (HALO) Enterprise Value Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Halozyme Therapeutics | 9.55 Bn | 9.23 Bn | 297.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.40% |
| Dec 31, 2025 | 76.04% |
| Sep 30, 2025 | -5.35% |
| Jun 30, 2025 | -3.62% |
| Mar 31, 2025 | -61.38% |
| Dec 31, 2024 | -77.40% |
| Sep 30, 2024 | -37.87% |
| Jun 30, 2024 | -51.90% |
| Mar 31, 2024 | -68.16% |
| Dec 31, 2023 | 7.39% |
| Sep 30, 2023 | -81.97% |
| Jun 30, 2023 | -66.35% |
| Mar 31, 2023 | 64.94% |
| Dec 31, 2022 | 51.03% |
| Sep 30, 2022 | 67.45% |
| Jun 30, 2022 | 72.28% |
| Mar 31, 2022 | -2.86% |
| Dec 31, 2021 | -101.33% |
| Sep 30, 2021 | -135.33% |
| Jun 30, 2021 | -95.96% |